Condition: Severe Hypertriglyceridemia · Sponsor: Eli Lilly and Company
The purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia. Participants will receive two subcutaneous injections.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Axsendo Clinical Research - Peak Heart & Vascular - Phoenix | Phoenix, Arizona, United States | Recruiting |
| Synexus Clinical Research US, Inc./Orange Grove Family Practice | Tucson, Arizona, United States | Recruiting |
| National Heart Institute | Beverly Hills, California, United States | Recruiting |
| Ark Clinical Research | Long Beach, California, United States | Recruiting |
| Catalina Research Institute, LLC | Montclair, California, United States | Recruiting |
| Valley Clinical Trials, LLC dba Flourish Research | Northridge, California, United States | Recruiting |
| CMR of Greater New Haven, LLC | Hamden, Connecticut, United States | Recruiting |
| Northeast Research Institute - Downtown Office | Jacksonville, Florida, United States | Recruiting |
| Novera Clinical Research | Miami, Florida, United States | Recruiting |
| Inpatient Research Clinic | Miami Lakes, Florida, United States | Recruiting |
| Clinical Site Partners, LLC dba Flourish Research | Winter Park, Florida, United States | Recruiting |
| Great Lakes Clinical Trials - Ravenswood | Chicago, Illinois, United States | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07269210